SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in Patients With HER2+/HER2-Low Advanced BC and Pathologically Confirmed Leptomeningeal Carcinomatosis"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in Patients With HER2+/HER2-Low Advanced BC and Pathologically Confirmed Leptomeningeal Carcinomatosis"

By Insights from 2023 SABCS FEATURING Marta Vaz Batista

163 views

December 18, 2023

0 Comments

London Breast Meeting 2024

Wed, Sep 4, 2024

11:31

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino

03:40

Integrity Continuing Education

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & …

Feat. A. Bardia

14:16

Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino

17:20

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino

57:44

Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl

16:02

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Feat. S. Bagley

49:07

SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo

22:34

Dana-Farber Cancer Institute

What's New in Breast Cancer?

Feat. S. Tolaney

17:35

Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino

23:58

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri

27:04

Fengting Yan

Cancer Screening Molecular Tools

30:46

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo

24:36

ESMO 2022 Conference Coverage

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

Feat. H. Rugo, J. O'Shaughnessy

07:23

Total Health

Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted…

Feat. R. O'Regan

24:10

Keck School of Medicine of USC

CDK4/6 Inhibitors in Breast Cancer: 2024 Update

Feat. R. O'Regan

29:40

Insights from 2023 SABCS

Year in Review: Metastatic Breast Cancer

Feat. M. Mac Gregor

12:21

Insights from 2023 SABCS

SABCS 2023 Insights: "How to Treat TNBC"

Feat. P. Sharma

06:47

UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang

13:23

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…

Feat. S. Hurvitz

17:33

Henry Friedman

Login

Login

Join VuMedi

SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in Patients With HER2+/HER2-Low Advanced BC and Pathologically Confirmed Leptomeningeal Carcinomatosis"

Related Content